The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (Pls) provide a framework for the implementation of TDM in certain defined scenarios in clinical practice. However, the utility of TDM is considered to be on an individual basis ...

In the past twenty years, 14 new antiepileptic drugs have been approved for use in the United States and/or Europe. These drugs are eslicarbazepine acetate, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, rufinamide, stiripentol, tiagabine, topiramate, vigabatrin and zonisamide. In general, the clinical utility of therapeutic drug monitoring has not bee...

Therapeutic Drug Monitoring In article number 2206753, Nathalia O. Gomes and Paulo A. Raymundo-Pereira report on personalized therapeutic drug monitoring (TDM) for subjects upon intake of acetaminophen oral pill tracking alterations in the analgesic concentration through changes oxidation current target naturally secreted saliva. The non-invasive method is made directly collected saliva at elec...